Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial.

Li, Bob T

Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology 08 2018 - 2532-2537 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1527-7755

10.1200/JCO.2018.77.9777 doi


Adenocarcinoma of Lung--drug therapy
Ado-Trastuzumab Emtansine
Aged
Antineoplastic Agents, Immunological--therapeutic use
Female
Humans
Lung Neoplasms--drug therapy
Male
Maytansine--analogs & derivatives
Middle Aged
Mutation
Receptor, ErbB-2--genetics
Trastuzumab--therapeutic use
Treatment Outcome